Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA health claims

This article was originally published in The Tan Sheet

Executive Summary

FDA health claims: Agency affirms 270-day timeframe for dietary supplement and food health claim decisions in a final rule published in the May 22 Federal Register. The agency proposed the 270-day period in a March 17 Federal Register notice after losing a federal court ruling to the Nutritional Health Alliance, which challenged the constitutionality of the Nutrition Labeling & Education Act ("The Tan Sheet" March 17, p. 13). FDA received four comments requesting shorter timetables; however, "none of these comments have demonstrated that a 270-day period is substantially excessive," the agency states. Among those commenting was NHA, which called the nine-month limit "excessive" and "unconstitutional" ("The Tan Sheet" April 21, p. 14). The final rule, which also permits FDA to grant itself two 90-day extensions rather than three, goes into effect June 23...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087089

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel